EUVIMEDEUVIMED entdecken
Leserbrief

‘Efficacy of anti‐IL ‐23 and anti‐IL ‐17 after adalimumab failure in psoriatic patients’—response to Yu et al.

L Mastorino iD, M Ortoncelli, P Dapavo, S Ribero iD, P Quaglino iD

Journal of the European Academy of Dermatology and Venereology · 2024

DOI: 10.1111/jdv.19517 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von L Mastorino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Psoriatic, Psoriasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antirheumatic AgentsArthritis, PsoriaticPsoriasisHumansAdalimumabAntibodies, MonoclonalTreatment Outcome

Substanzen

AdalimumabAntirheumatic AgentsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.

ORCID-Profile: L Mastorino, S Ribero, P Quaglino

Zitieren

APA

Mastorino, L., Ortoncelli, M., Dapavo, P., Ribero, S., & Quaglino, P. (2024). ‘Efficacy of anti‐IL ‐23 and anti‐IL ‐17 after adalimumab failure in psoriatic patients’—response to Yu et al. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19517

Vancouver

Mastorino L, Ortoncelli M, Dapavo P, Ribero S, Quaglino P. ‘Efficacy of anti‐IL ‐23 and anti‐IL ‐17 after adalimumab failure in psoriatic patients’—response to Yu et al. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19517

BibTeX
@article{Mastorino2024,
  author = {Mastorino, L and Ortoncelli, M and Dapavo, P and Ribero, S and Quaglino, P},
  title = {‘Efficacy of anti‐IL ‐23 and anti‐IL ‐17 after adalimumab failure in psoriatic patients’—response to Yu et al},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  doi = {10.1111/jdv.19517}
}
Kostenlos starten →